Eikonoklastes Therapeutics
Zhiwei Hu is a Scientific Co-Founder at Eikonoklastes Therapeutics.
This person is not in any offices
Eikonoklastes Therapeutics
1 followers
Eikonoklastes is advancing a new generation of tissue factor (TF) immunotherapies – therapeutics designed to target the cell surface receptor now known to be prevalent on key components of the tumor microenvironment.